The objective of our work is to study the multi-systemic inflammatory
syndrome (PIMS) in children, to determine its frequency, by analyzing the
epidemiological, clinical, paraclinical, therapeutic, and evolutionary profile
of these patients. A retrospective study spanning a period of 2 years from
April 2020 to March 2022. It concerns all children under the age of 16 admitted
and cared for in the pediatric emergency department of the university hospital
Hassan II of Fez for multi-system inflammatory syndrome (PIMS). Twenty cases of PIMS were collected over this period.
Multi-system inflammatory syndrome in children has been described in temporal
association with COVID-19, usually within 2 to 6 weeks of illness or
exposure. The age of the patients varies between 8 months and 15 years. All
patients presented with fever and cutaneous signs, followed by digestive signs
and neurological signs. The inflammatory syndrome is frankly positive in all
patients who had a COVID-19 PCR and/or positive serology. The treatment is
based on the administration of immunoglobulins
in association with corticosteroid therapy and non-specific antibiotic
therapy in the majority of cases (80%). The evolution was favorable. PIMS
should be considered in all children presenting with a clinical and/or
biological inflammatory syndrome associated with COVID-19.
References
[1]
Organisation mondiale de la Santé (2020) Syndrome inflammatoire multisystémique chez les enfants et les adolescents atteints de COVID-19: Note scientifique, 15 mai 2020. https://apps.who.int/iris/handle/10665/332190
[2]
Royal College of Paediatrics and Child Health (2020) Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19. Royal College of Paediatrics and Child Health Leading the Way in Children’s Health.
https://www.rcpch.ac.uk/resources/paediatricmultisystem-inflammatory-syndrome-temporally-associated-covid-19-pimsguidance
[3]
Herman, A., Peeters, C., Verroken, A., Tromme, I., Tennstedt, D., Marot, L., et al. (2020) Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic. JAMA Dermatology, 156, 998-1003.
https://doi.org/10.1001/jamadermatol.2020.2368
[4]
Pouletty, M., Borocco, C., Ouldali, N., Caseris, M., Basmaci, R., Lachaume, N., et al. (2020) Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 Mimicking Kawasaki Disease (Kawa-COVID-19): A Multicentre Cohort. Annals of the Rheumatic Diseases, 79, 999-1006.
https://doi.org/10.1136/annrheumdis-2020-217960
[5]
Dufort, E.M., Koumans, E.H., Chow, E.J., Rosenthal, E.M., Muse, A., Rowlands, J., et al. (2020) Multisystem Inflammatory Syndrome in Children in New York State. The New England Journal of Medicine, 383, 347-358.
https://doi.org/10.1056/NEJMoa2021756
[6]
Bajolle, F. (2021) Syndrome Inflammatoire Avec Atteinte Multisystémique Post-Infection par le SARS-CoV-2 chez l’enfant: Quand l’envisager et comment le prendre en charge? Perfectionnement en Pédiatrie, 4, 10-16.
https://doi.org/10.1016/j.perped.2020.11.001
[7]
Whittaker, E., Bamford, A., Kenny, J., et al. (2020) Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. JAMA, 324, 259-269.
https://doi.org/10.1001/jama.2020.10369
[8]
Feldstein, L.R., Rose, E.B., Horwitz, S.M., Collins, J.P., Newhams, M.M., Son, M.B.F., et al. (2020) Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. The New England Journal of Medicine, 383, 334-346.
[9]
Encinosa, W., Moon, K., Figueroa, J. and Elias, Y. (2023) Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19. JAMA Network Open, 6, e2244975.
https://doi.org/10.1001/jamanetworkopen.2022.44975
[10]
Hajiani Ghotbabadi, S., Mollaie, M., Hamzavi, S.S. and Sanaei Dashti, A. (2022) Clinical and Laboratory Characteristics of the Multisystem Inflammatory Syndrome in Children: A Case Series of 75 Patients. Archives of Pediatric Infectious Diseases, 10, e120863. https://doi.org/10.5812/pedinfect-120863
[11]
Kim, M.M., Murthy, S. and Goldman, R.D. (2021) Le syndrome inflammatoire multi systémique post-COVID-19 chez les enfants. Canadian Family Physician, 67, e224-e226. https://doi.org/10.46747/cfp.6708e224
[12]
Henry, B.M., Benoit, S.W., de Oliveira, M.H.S., Hsieh, W.C., Benoit, J., Ballout, R.A., Plebani, M. and Lippi, G. (2020) Laboratory Abnormalities in Children with Mild and Severe Coronavirus Disease 2019 (COVID-19): A Pooled Analysis and Review. Clinical Biochemistry, 81, 1-8.
https://doi.org/10.1016/j.clinbiochem.2020.05.012
[13]
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., et al. (2020) An Outbreak of Severe Kawasaki-Like Disease at the Italian Epicentre of the SARS-CoV-2 Epidemic: An Observational Cohort Study. The Lancet, 395, 1771-1778.
https://doi.org/10.1016/S0140-6736(20)31103-X
[14]
Sa, M., Mirza, L., Carter, M., Carlton Jones, L., Gowda, V., Handforth, J., Hedderly, T., et al. (2021) Systemic Inflammation Is Associated with Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated with SARS-CoV-2. Neurology Neuroimmunology & Neuroinflammation, 8, e999.
https://doi.org/10.1212/NXI.0000000000000999
[15]
Miller, J., Cantor, A., Zachariah, P., Ahn, D., Martinez, M. and Margolis, K.G. (2020) Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases. Gastroenterology, 159, 1571-1574.E2. https://doi.org/10.1053/j.gastro.2020.05.079
[16]
Capone, C.A., Subramony, A., Sweberg, T., Schneider, J., Shah, S., Rubin, L., Schleien, C., the Northwell Health COVID-19 Research Consortium, Epstein, S., Johnson, J.C., Kessel, A., Misra, N., Mitchell, E., Palumbo, N., Rajan, S., Rocker, J., Williamson, K. and Davidson, K.W. (2020) Characteristics, Cardiac Involvement, and Outcomes of Multisystem Inflammatory Syndrome of Childhood Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection. The Journal of Pediatrics, 224, 141-145. https://doi.org/10.1016/j.jpeds.2020.06.044
[17]
Toubiana, J., Poirault, C., Corsia, A., Bajolle, F., Fourgeaud, J., Angoulvant, F., et al. (2020) Kawasaki-Like Multisystem Inflammatory Syndrome in Children during the Covid-19 Pandemic in Paris, France: Prospective Observational Study. The BMJ, 369, m2094. https://doi.org/10.1136/bmj.m2094
[18]
Cantor, A., Miller, J., Zachariah, P., DaSilva, B., Margolis, K. and Martinez, M. (2020) Acute Hepatitis Is a Prominent Presentation of the Multisystem Inflammatory Syndrome in Children: A Single-Center Report. Hepatology, 72, 1522-1527.
https://doi.org/10.1002/hep.31526
[19]
Zhang, Y.F., Zheng, L., Liu, L., Zhao, M.Y., Xiao, J. and Zhao, Q. (2020) Liver Impairment in COVID-19 Patients: A Retrospective Analysis of 115 Cases from a Single Centre in Wuhan City, China. Liver International, 40, 2095-2103.
https://doi.org/10.1111/liv.14455
[20]
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., et al. (2020) Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study. The BMJ, 368, m1091. https://doi.org/10.1136/bmj.m1091
[21]
Huang, J., Cheng, A., Kumar, R., Fang, Y., Chen, G., Zhu, Y., et al. (2020) Hypoalbuminemia Predicts the Outcome of COVID-19 Independent of Age and Co-Morbidity. Journal of Medical Virology, 92, 2152-2158. https://doi.org/10.1002/jmv.26003
[22]
Levin, M. (2020) Childhood Multisystem Inflammatory Syndrome—A New Challenge in the Pandemic. The New England Journal of Medicine, 383, 393-395.
https://doi.org/10.1056/NEJMe2023158
[23]
Société Française de Pédiatrie (2022) Réponse rapide dans le cadre de la COVID-19: Repérage et prise en charge du syndrome inflammatoire multi-systémique pédiatrique (PIMS) post-infectieux.
[24]
Ashlesha, K., Sandeep, G., Mangla, S., Seema, S. and Shikha. V. (2020) A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection. The Pediatric Infectious Disease Journal, 39, e340-e346.
https://doi.org/10.1097/INF.0000000000002888
